Beyond Air, Inc. (XAIR)
NASDAQ: XAIR · Real-Time Price · USD
0.4810
-0.0169 (-3.39%)
At close: May 18, 2026, 4:00 PM EDT
0.4850
+0.0040 (0.83%)
After-hours: May 18, 2026, 4:28 PM EDT
Beyond Air Employees
Beyond Air had 61 employees as of March 31, 2025. The number of employees decreased by 46 or -42.99% compared to the previous year.
Employees
61
Change (1Y)
-46
Growth (1Y)
-42.99%
Revenue / Employee
$113,508
Profits / Employee
-$508,213
Market Cap
6.35M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2025 | 61 | -46 | -42.99% | 61 | 0 |
| Mar 31, 2024 | 107 | 9 | 9.18% | 107 | 0 |
| Mar 31, 2023 | 98 | 36 | 58.06% | 98 | 0 |
| Mar 31, 2022 | 62 | 21 | 51.22% | 62 | 0 |
| Mar 31, 2021 | 41 | 18 | 78.26% | 41 | 0 |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Trinity Biotech | 401 |
| Vivos Therapeutics | 268 |
| Co-Diagnostics | 115 |
| Intelligent Bio Solutions | 55 |
| Biomerica | 54 |
| enVVeno Medical | 33 |
| Sintx Technologies | 32 |
| Tenon Medical | 26 |
XAIR News
- 4 weeks ago - Beyond Air’s Beyond Cancer reports updated data from Phase 1 UNO trial - TheFly
- 4 weeks ago - Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026 - GlobeNewsWire
- 4 weeks ago - Beyond Air to Participate in the D. Boral Capital Global Conference 2026 - GlobeNewsWire
- 7 weeks ago - Beyond Air CEO Steve Lisi resigns, Robert Goodman succeeds - TheFly
- 2 months ago - Beyond Air subsidiary reports signs of clinical activity from UNO trial - TheFly
- 2 months ago - Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial - GlobeNewsWire
- 2 months ago - Beyond Air Transcript: Life Sciences Virtual Investor Forum - Transcripts
- 2 months ago - Beyond Air announces termination of NeuroNOS agreement with XTL - TheFly